Literature DB >> 31938428

PAK4 enhances TGF-β1-induced epithelial-mesenchymal transition through activating β-catenin signaling pathway in renal tubular epithelial cells.

Yan Fan1, Xv Wang2, Yang Li3, Xing Zhao1, Jieqing Zhou1, Xiaoxue Ma1, Dong An1, Hong Jiang1.   

Abstract

Epithelial-mesenchymal transition (EMT) of renal tubular epithelial cells contributes to development and progression of renal interstitial fibrosis in CKD. p21-activated kinase 4 (PAK4) is a member of serine/threonine protein kinases but the role of PAK4 in renal fibrosis remains unknown. In this study, we investigated the effects of PAK4 on transforming growth factor-β1 (TGF-β1)-treated human renal tubular epithelial cells (HK-2 cells) and aimed to elucidate probable mechanisms for its fibrogenic effects. Our results revealed that PAK4 was highly expressed in TGF-β1-treated HK-2 cells. Overexpressing PAK4 could further decrease TGF-β1-induced E-cadherin expression and increase TGF-β1-induced fibronectin and vimentin expression in HK-2 cells. In addition, overexpressing PAK4 could promote the translocation of β-catenin from cell membranes into the nucleus in TGF-β1-treated HK-2 cells. These results indicate that PAK4 could enhance TGF-β1-induced EMT in renal tubular epithelial cells. Our findings indicate that PAK4 may promote renal interstitial fibrosis by activating β-catenin signaling pathway. Thus, we suggest that PAK4 might be a potential therapeutic target for ameliorating renal interstitial fibrosis. IJCEP
Copyright © 2018.

Entities:  

Keywords:  beta-catenin; epithelial-mesenchymal transition (EMT); p21-activated kinase 4 (PAK4); renal interstitial fibrosis (RIF); transforming growth factor beta 1 (TGF-β1)

Year:  2018        PMID: 31938428      PMCID: PMC6958077     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  2 in total

1.  Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cells.

Authors:  Peilu Song; Fan Zhao; Dahong Li; Jiqiang Qu; Miao Yao; Yuan Su; Hanxun Wang; Miaomiao Zhou; Yujie Wang; Yinli Gao; Feng Li; Dongmei Zhao; Fengjiao Zhang; Yu Rao; Mingyu Xia; Haitao Li; Jian Wang; Maosheng Cheng
Journal:  Acta Pharm Sin B       Date:  2022-03-04       Impact factor: 14.903

2.  CEACAM5 stimulates the progression of non-small-cell lung cancer by promoting cell proliferation and migration.

Authors:  Xinwen Zhang; Xingbao Han; Pengli Zuo; Xiuying Zhang; Hongbang Xu
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.